[go: up one dir, main page]

DK1976538T3 - Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid - Google Patents

Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid

Info

Publication number
DK1976538T3
DK1976538T3 DK06841087T DK06841087T DK1976538T3 DK 1976538 T3 DK1976538 T3 DK 1976538T3 DK 06841087 T DK06841087 T DK 06841087T DK 06841087 T DK06841087 T DK 06841087T DK 1976538 T3 DK1976538 T3 DK 1976538T3
Authority
DK
Denmark
Prior art keywords
acid
treatment
pharmaceutical formulation
hyaluronic acid
osteoarthritis containing
Prior art date
Application number
DK06841087T
Other languages
Danish (da)
Inventor
Sergio Rosini
Silvia Trasciatti
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Application granted granted Critical
Publication of DK1976538T3 publication Critical patent/DK1976538T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)

Abstract

Disclosed are pharmaceutical compositions containing clodronic acid and hyaluronic acid or their salts as active constituents, mixed with suitable vehicles.
DK06841087T 2005-12-29 2006-12-21 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid DK1976538T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002515A ITMI20052515A1 (en) 2005-12-29 2005-12-29 PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF OSTEOARTRITE
PCT/EP2006/012367 WO2007073921A1 (en) 2005-12-29 2006-12-21 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid

Publications (1)

Publication Number Publication Date
DK1976538T3 true DK1976538T3 (en) 2010-01-11

Family

ID=36648609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06841087T DK1976538T3 (en) 2005-12-29 2006-12-21 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid

Country Status (20)

Country Link
US (4) US20090042833A1 (en)
EP (1) EP1976538B1 (en)
JP (1) JP2009522218A (en)
KR (2) KR20140107651A (en)
AT (1) ATE446763T1 (en)
AU (1) AU2006331019B2 (en)
CA (1) CA2646974C (en)
CY (1) CY1109541T1 (en)
DE (1) DE602006010111D1 (en)
DK (1) DK1976538T3 (en)
ES (1) ES2333615T3 (en)
IT (1) ITMI20052515A1 (en)
NO (1) NO340794B1 (en)
NZ (1) NZ569420A (en)
PL (1) PL1976538T3 (en)
PT (1) PT1976538E (en)
RU (1) RU2414908C2 (en)
SI (1) SI1976538T1 (en)
WO (1) WO2007073921A1 (en)
ZA (1) ZA200805598B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120208757A1 (en) * 2010-10-07 2012-08-16 Excel Med, Llc Use of hyaluronan for promoting angiogenesis
RU2710373C2 (en) 2014-11-07 2019-12-26 Экзостемтех Ко., Лтд. Composition comprising exosomes prepared from stem cells for induction of adipogenic differentiation, regeneration of adipose tissue, skin bleaching or wrinkle correction
KR101706642B1 (en) 2015-02-04 2017-02-17 주식회사 엑소스템텍 Composition comprising exosomes extracted from stem cells which differentiate into chondrocytes for inducing chondrogenic differentiation or regenerating cartilage tissue
IT201600123773A1 (en) 2016-12-06 2018-06-06 Abiogen Pharma Spa COMPOSITION FOR THE TREATMENT OF OSTEOARTROSI
IT202100023894A1 (en) * 2021-09-16 2023-03-16 Professional Derma Sa Composition for use in the orthopedic field
EP4450062A1 (en) 2023-04-20 2024-10-23 Abiogen Pharma S.p.A. Composition for the treatment of osteoarthrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187828B (en) * 1985-05-24 1987-12-23 Gentili Ist Spa PHARMACEUTICAL COMPOSITION BASED ON DIPHOSPHONATES FOR THE TREATMENT OF ARETROSIS
JP2001253827A (en) * 2000-02-15 2001-09-18 Pfizer Prod Inc Composition and method for treating osteoporosis
JP3923800B2 (en) * 2000-05-05 2007-06-06 エフ．ホフマン−ラ ロシュ アーゲー Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acid or a salt thereof
EP1519744A4 (en) * 2002-05-17 2007-10-03 Wyeth Corp SOLID INJECTABLE VEHICLES CONTAINING HYALURONIC ACID FOR ADMINISTRATION OF OSTEOGENIC PROTEINS
WO2005105058A1 (en) * 2004-05-04 2005-11-10 Amorepacific Corporation Sustained-releasing injectable formulation for the treatment or prevention of bone-related diseases comprising bisphorenate-containing polymeric microparticles

Also Published As

Publication number Publication date
NO20082848L (en) 2008-08-27
DE602006010111D1 (en) 2009-12-10
EP1976538B1 (en) 2009-10-28
JP2009522218A (en) 2009-06-11
ES2333615T3 (en) 2010-02-24
WO2007073921A1 (en) 2007-07-05
CA2646974A1 (en) 2007-07-05
EP1976538A1 (en) 2008-10-08
NO340794B1 (en) 2017-06-19
US20140371170A1 (en) 2014-12-18
KR20080082657A (en) 2008-09-11
KR20140107651A (en) 2014-09-04
NZ569420A (en) 2010-05-28
US20200147126A1 (en) 2020-05-14
AU2006331019A1 (en) 2007-07-05
KR101470608B1 (en) 2014-12-09
ITMI20052515A1 (en) 2007-06-30
RU2414908C2 (en) 2011-03-27
US20180185407A1 (en) 2018-07-05
SI1976538T1 (en) 2010-01-29
PT1976538E (en) 2009-12-07
ATE446763T1 (en) 2009-11-15
AU2006331019A2 (en) 2009-01-22
CY1109541T1 (en) 2014-08-13
US20090042833A1 (en) 2009-02-12
HK1123986A1 (en) 2009-07-03
PL1976538T3 (en) 2010-03-31
AU2006331019B2 (en) 2012-03-22
ZA200805598B (en) 2009-11-25
RU2008126108A (en) 2010-01-10
US9943540B2 (en) 2018-04-17
CA2646974C (en) 2013-06-11

Similar Documents

Publication Publication Date Title
EA201170772A1 (en) ORGANIC COMPOUNDS
EA200870217A1 (en) 4-Aryl-2-aminopyrimidines or 4-aryl-2-aminoalkylpyrimidines as modulators JAK-2 and containing their pharmaceutical compositions
MX2009004714A (en) 3-aminocarbonyi-substituted fused pyrazolo-derivatives as protein kinase modulators.
CY1110813T1 (en) CHEMICAL COMPOUNDS
UY31673A1 (en) "UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211"
ATE470443T1 (en) INDOL-1-YL ACID DERIVATIVES
CY1109916T1 (en) Benzimidazolo-thiophene compounds as PLK inhibitors
EA201170508A1 (en) DERIVATIVES OF 1-AMINO-2-CYCLOBUTYLETHYLBURONIC ACID
NO20074823L (en) Rasagilin formulations with improved content uniformity
NO20075111L (en) Pharmaceutical composition
EA200802184A1 (en) PHARMACEUTICAL COMPOSITIONS WITH DPP IV INHIBITORS
NO20064584L (en) Tetrahydropyridoindolderivater
WO2006086562A3 (en) Phenylazetidinone derivatives
HN2008000311A (en) CRYSTAL FORMS OF 4-METHYL-N- [3- (4-METHYL-IMIDAZOL-1-IL) -5-TRIFLUOROMETIL-PHENYL] -3- (4-PIRIDIN-3-IL-PIRIMIDIN-2-ILAMINO) -BENZAMIDA
EP2535058A3 (en) Stabilization of vaccines by lyophilization
CL2007001710A1 (en) Substituted amino-pyrazolopyridine derivatives; Preparation method; pharmaceutical composition; and use in the treatment of diseases such as tumors, rheumatoid arthritis, diseases of deregulated vascular growth, among others.
DE502004002571D1 (en) SUBSTITUTED 3-PYRROLIDIN INDOL DERIVATIVES
EA200900267A1 (en) COMPOSITION FOR AEROSOL INHALATION OF β-AGONISTS AND STEROIDS
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
EA201001196A1 (en) 4-PYRIDINONE COMPOUNDS AND THEIR APPLICATION FOR CANCER TREATMENT
TW200738659A (en) Novel compounds
CL2008003659A1 (en) Compounds derived from 6- (4-benzylpiperazin-1-yl) pyrimidin-4-one, modulators of the enzyme stearoyl-coa-desaturase 1; preparation procedure; pharmaceutical composition; and use in the treatment and prophylaxis of obesity.
NO20082848L (en) Pharmaceutical Formulation for the Treatment of Osteoarthritis Containing Clodronic Acid and Hyaluronic Acid
DK1869038T3 (en) Substituted 5,6,7,8-tetrahydro-imidazole [1,2-a] pyridin-2-ylamine compounds and their use in the manufacture of drugs
TW200800993A (en) Organic compounds